HCID 57794622, compound → HCID 11377034, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][N:15]2[C:19]([CH:20]([NH:32][C:33]([N:35]3[CH2:40][CH2:39][CH:38]([N:41]4[CH2:50][C:49]5[C:44](=[C:45]([F:51])[CH:46]=[CH:47][CH:48]=5)[NH:43][C:42]4=[O:52])[CH2:37][CH2:36]3)=[O:34])[CH2:21][C:22]3[CH:23]=[C:24]4[C:28](=[C:29]([CH3:31])[CH:30]=3)[NH:27][N:26]=[CH:25]4)=[N:18][N:17]=[N:16]2)[CH2:10][CH2:9]1)=O)(C)(C)C>FC(F)(F)C(O)=O.C(Cl)Cl>[F:51][C:45]1[CH:46]=[CH:47][CH:48]=[C:49]2[C:44]=1[NH:43][C:42](=[O:52])[N:41]([CH:38]1[CH2:37][CH2:36][N:35]([C:33]([NH:32][CH:20]([C:19]3[N:15]([CH2:14][CH:11]4[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]4)[N:16]=[N:17][N:18]=3)[CH2:21][C:22]3[CH:23]=[C:24]4[C:28](=[C:29]([CH3:31])[CH:30]=3)[NH:27][N:26]=[CH:25]4)=[O:34])[CH2:40][CH2:39]1)[CH2:50]2Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
tert-Butyl-4-({5-(1-[4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3[4H]-yl)piperidine-1-carboxamido]-2-(7-methyl-1H-indazol-5-yl)ethyl)-1H-tetrazol-1-yl}methyl)piperidine-1-carboxylate (10 mg, 0.014 mmol) was dissolved in a 1:1 mixture of trifluoroacetic acid and methylene chloride (1.0 mL) and stirred at room temperature for 30 min. The solvent was removed under reduced pressure and the compound dried in vacuo for 2 h to afford 5.9 mg (68%). 1H-NMR (CD3OD, 500 MHz) δ 1.20-1.48 (m, 4H), 1.50-1.79 (m, 5H) 2.24 (dd, J=12.5, 8.6, 1H), 2.50 (s, 3H), 2.57 (dd, J=11.6, 11.3, 1H), 3.18 (bs, 2H), 3.47 (s, 1H), 4.01-4.40 (m, 7H), 5.29 (dd, J=8.2, 7.9, 1H), 6.90-7.15 (m, 4H), 7.37 (s, 1H), 7.98 (s, 1H), 8.00 (s, 1H). Mass spec.: 616.20 (MH)+.
Workup
- customThe solvent was removed under reduced pressure
- customthe compound dried in vacuo for 2 h
- customto afford 5.9 mg (68%)
Sources & evidence
- ORD record
- ord-39ba12493db341e79e219d2f9ec9a6a3
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07569578B2
Reaction notes
Loading…